Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.

European journal of haematology - 1 Feb 2013

Verstovsek Srdan

Abstract excerpt

Apart from indolent systemic mastocytosis (SM), which is associated with a favorable prognosis, other subtypes of SM (SM with associated clonal hematologic non-mast cell lineage disease, aggressive SM, and mast cell leukemia - collectively referred to in this review as advanced SM) can be debilitating. The complexity of SM makes both the diagnosis and design of response criteria challenging for clinical studies....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Delivery Systems
Share to Enzyme Activation
Share to KIT gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mast Cells

Share to Mast cells and histamine

Share to Mutation

Share to Protein Structure, Tertiary

Share to Proto-Oncogene Proteins c-kit

Source

Open in PubMed Open full text

Identifiers

PMID: 23181448
DOI: 10.1111/ejh.12043
PMCID: PMC3761194

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.PMID 23181448Read ↗

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.Semantic proximity Read ↗

Molecular defects in mastocytosis: KIT and beyond KIT.Semantic proximity Read ↗

KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis.Semantic proximity Read ↗

How we diagnose and treat systemic mastocytosis in adults.Semantic proximity Read ↗

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice.Semantic proximity Read ↗

Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosisSemantic proximity Read ↗

Precision Medicine in Systemic Mastocytosis.Semantic proximity Read ↗

Diagnosis, progression patterns and prognostication in mastocytosis.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Systemic Mastocytosis: State of the Art.Semantic proximity Read ↗

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.